Pancreatic cancer is usually detected too late, leaving patients little hope of recovery. But this may be about to change. A Swedish SME has developed a blood test to help clinicians identify new cases earlier, and it intends to make this diagnostic capability available very soon. Clinical validation is under way in an EU-funded project.from EUROPA - Syndicated Research News Feed http://ift.tt/1WJuELV
via IFTTT
No comments:
Post a Comment